Indole derivatives confer protection in murine models of colitis, largely via AhR activation, leading to increased IL-22 production by ILC3s and T cells that drives improved intestinal barrier integrity, reduced inflammation, and, ultimately, disease amelioration [20, 22, 28, 62–64]. The gene discussed is IL22; the disease is colitis.